Palmar plantar erythrodysesthesia epidemiology and demographics: Difference between revisions
Mchitsazan (talk | contribs) |
Mchitsazan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Palmar plantar erythrodysesthesia}} | {{Palmar plantar erythrodysesthesia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MC}} | ||
==Overview== | ==Overview== | ||
Estimated incidence of PPE is 6 to 64% of patients treated with chemotherapeutic drugs. However, the exact incidence of PPE is unknown, as most reports are isolated case reports or short case series. | Estimated incidence of PPE is 6 to 64% of patients treated with chemotherapeutic drugs. However, the exact incidence of PPE is unknown, as most reports are isolated case reports or short case series. | ||
Revision as of 17:06, 2 July 2019
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia epidemiology and demographics |
|
FDA on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
CDC on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Palmar plantar erythrodysesthesia epidemiology and demographics in the news |
|
Blogs on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Estimated incidence of PPE is 6 to 64% of patients treated with chemotherapeutic drugs. However, the exact incidence of PPE is unknown, as most reports are isolated case reports or short case series.
Epidemiology and Demographics
Incidence
It is difficult to determine the actual incidence of PPE as most reports in the literature are isolated case reports or short case series.
Estimating based on some case series, PPE has been reported to occur in 6 to 64% of patients treated with different chemotherapy regimens. [1]
References
- ↑ L. Hueso, O. Sanmartin, E. Nagore, R. Botella-Estrada, C. Requena, B. Llombart, C. Serra-Guillen, A. Alfaro-Rubio & C. Guillen. "[Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases]". Actas dermo-sifiliograficas. PMID 18394404.